← Scroll for more →
Financial Statements — LIFE
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 112.16 | 107.91 | 91.09 |
| Short-term Investments | 56.16 | 36.69 | 34.88 |
| Total Current Assets | 302.00 | 259.35 | 245.80 |
| Total Assets | 696.08 | 619.36 | 515.34 |
| Total Current Liabilities | 199.05 | 154.96 | 113.19 |
| Total Liabilities | 219.92 | 178.04 | 135.46 |
| Retained Earnings | (249.37) | (268.90) | (102.51) |
| Total Stockholder Equity | 476.17 | 441.32 | (24.12) |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Revenue | 189.56 | 193.10 |
| Operating Income | 18.12 | (163.31) |
| Tax Provision | (0.21) | 3.85 |
| Net Income | 19.53 | (166.39) |
| Diluted EPS | 0.30 | (3.57) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | 35.66 | 31.21 |
| Capital Expenditures | 0.33 | 0.35 |
| Free Cash Flow* | 35.34 | 30.86 |
| Investing Cash Flow | (26.99) | (52.10) |
| Financing Cash Flow | (4.41) | 37.78 |
← Scroll for more columns →
* Derived from reported values